Silk fibroin (SF) is a protein produced by silkworms and spiders. It has exceptional mechanical properties as well as excellent physical and chemical properties such as excellent biocompatibility, tunable degradation, and ease of processing. The material also has the ability to support differentiation of the mesenchymal stem cells along the osteogenic lineage. These properties have made silk fibroin a favorable scaffold material for bone tissue engineering. Silk fibroin can be processed into various forms such as fibers, films, and particulate and three-dimensional (3D) porous scaffolds.
Silk fibroin can also be synergistically combined with other biomaterials to form various composites. Also, it can be chemically modified for different applications. Silk fibroin is widely used in various biomedical applications, due to its superior biocompatibility, tunable degradation, and excellent mechanical properties. Researchers are developing methods to utilize silk fibroin biomaterials for repairing the ocular surface of the cornea on injury, for which the currently available biomaterials are partially effective. This can generate demand for use of silk fibroin biomaterials in eye care applications.
Based on region, the global silk fibroin market can be segregated into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. North America and Europe are anticipated to collectively constitute a major share of the global market during the forecast period. The silk fibroin market in Asia Pacific is likely to expand at a significant pace due to the rise in per capita income in developing countries in the region such as China and India. Rise in the per capita income increases spending power of consumers, which raises the demand for high-quality health care products in the region. This, coupled with increasing prevalence of bone-related diseases, fuels the silk fibroin market in Asia Pacific. Middle East & Africa is expected to be an attractive market for silk fibroin during the forecast period, due to rise in the demand for silk fibroin in the region for use in health care applications.